OBJECTIVE: To evaluate the clinical effects of the low power and negative power acrylic foldable intraocular lens (Acrysof IOL) implantation. METHODS: Forty patients (56 eyes) received phacoemulsification and above mentioned Acrysof IOL implantation. Intraoperative and postoperative complications, visual acuity and refractive error were observed. RESULTS: No intraoperative complications occurred. During 3 months of follow-up, the corrected visual acuity was less than 0.1 in 2 eyes, 0.1 - 0.4 in 12 eyes, 0.5 - 0.9 in 36 eyes, and 1.0 - 1.5 in 6 eyes. Posterior capsular opacification was found in 4 eyes (7.2%). Capsular distension was found in 1 eye (1.8%). No retinal detachment was seen. CONCLUSION: It is safe and effective for highly myopic patients with cataract to implant a low or negative power Acrysof IOL after phacoemulsification.
OBJECTIVE: To evaluate the clinical effects of the low power and negative power acrylic foldable intraocular lens (Acrysof IOL) implantation. METHODS: Forty patients (56 eyes) received phacoemulsification and above mentioned Acrysof IOL implantation. Intraoperative and postoperative complications, visual acuity and refractive error were observed. RESULTS: No intraoperative complications occurred. During 3 months of follow-up, the corrected visual acuity was less than 0.1 in 2 eyes, 0.1 - 0.4 in 12 eyes, 0.5 - 0.9 in 36 eyes, and 1.0 - 1.5 in 6 eyes. Posterior capsular opacification was found in 4 eyes (7.2%). Capsular distension was found in 1 eye (1.8%). No retinal detachment was seen. CONCLUSION: It is safe and effective for highly myopic patients with cataract to implant a low or negative power Acrysof IOL after phacoemulsification.